Cochrane Abstracts
Galantamine for dementia due to Alzheimer's disease and mild cognitive impairment
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Galantamine for Dementia Due to Alzheimer's Disease and Mild Cognitive Impairment." Cochrane Abstracts, John Wiley & Sons, Inc, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434631/all/Galantamine_for_dementia_due_to_Alzheimer&apos.
Galantamine for dementia due to Alzheimer's disease and mild cognitive impairment. Cochrane Abstracts. John Wiley & Sons, Inc; 2026. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434631/all/Galantamine_for_dementia_due_to_Alzheimer&apos. Accessed February 7, 2026.
Galantamine for dementia due to Alzheimer's disease and mild cognitive impairment. (2026). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434631/all/Galantamine_for_dementia_due_to_Alzheimer&apos
Galantamine for Dementia Due to Alzheimer's Disease and Mild Cognitive Impairment [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2026. [cited 2026 February 07]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434631/all/Galantamine_for_dementia_due_to_Alzheimer&apos.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Galantamine for dementia due to Alzheimer's disease and mild cognitive impairment
ID - 434631
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434631/all/Galantamine_for_dementia_due_to_Alzheimer&apos
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
